Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
1st March 2008
American Academy of Family Physicians - Medical Specialty Society
American College of Physicians - Medical Specialty Society
Summary,
American Academy of Family Physicians - Medical Specialty Society
American College of Physicians - Medical Specialty Society
Summary,
GUIDELINE OBJECTIVE(S)
To present the available evidence on current pharmacologic treatment of dementia
TARGET POPULATION
Adults 18 years or older with a diagnosis of dementia
INTERVENTIONS AND PRACTICES CONSIDERED
Use of cholinesterase inhibitors and memantine for selected patients
MAJOR OUTCOMES CONSIDERED
* Cognition
* Global function
* Behavior/mood
* Quality of life/activities of daily living
* Caregiver burden
* Adverse effects of medications
* Rate of institutionalization
* Mortality
Specialities:
- Neurology
- ADHD
- Advanced Parkinson's Disease
- Anxiety Disorder
- Brain Cancer
- Cerebrovascular Disease
- Dementia
- Epilepsy
- Mood Disorders
- Motor/Movement Disorder
- Multiple Sclerosis
- Neuroimaging
- Neurosurgery
- Obsessive-Compulsive Disorder
- Pain/Headache
- Parkinson's Disease
- Psychiatry
- Schizophrenia
- Sleep Disorder
- Stroke
- 12 September 2010
- 21 September 2010
- 22 September 2010






